Role of leukotriene B4 receptors in the interplay of inflammation and infection

白三烯 B4 受体在炎症和感染相互作用中的作用

基本信息

  • 批准号:
    8433515
  • 负责人:
  • 金额:
    $ 27.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Colon cancer is a leading cause of cancer related deaths in the United States. Exposure to a number of hazardous environmental agents and consumption of the Western diet are known to contribute to the pathogenesis of malignant colon cancer. While chronic inflammation is known to be a major promoter of tumor development the role of gut microflora in contributing to the colon cancer is unknown. Our laboratory has identified leukotriene B4 receptor, BLT1 as a major regulator of inflammation and host response to infections. In a mouse model of spontaneous intestinal cancer (ApcMin/+), we have made the observation that absence of BLT1 greatly enhances intestinal tumor development. This has led to the central hypothesis that Absence of BLT1 enhances colon tumor development by defective immune surveillance and/or altered microbial gut homeostasis. This apparently paradoxical result that loss of a proinflammatory mediator increases inflammation and tumor development suggests that the ever changing micro environment of intestine can have a major influence on the development of colorectal cancer. The current proposal will test this hypothesis in three specific aims. In aim 1, we will examine the mechanisms of leukotriene B4 pathway mediated protection of intestinal cancers in ApcMin/+ mice. Aim 2 will establish the immune functions in tumor bearing mice in the context of BLT1+/+ and BLT1-/- mice. Aim 3 will test the novel concept that defective host response and altered gut microbiota are responsible for rapid development of colon tumors in BLT1-/- mice. These studies will provide a comprehensive model system to examine the interplay of inflammation and infections to the development of colon cancer. Since the mouse ApcMin/+ model is highly related to human colon cancers the result will have direct and immediate impact for the treatment of human colon cancer.
描述(由申请人提供):结肠癌是美国癌症相关死亡的主要原因。暴露于一些有害的环境因素和西方饮食的消费是已知的恶性结肠癌的发病机制。虽然已知慢性炎症是肿瘤发展的主要促进因素,但肠道微生物群在促成结肠癌中的作用尚不清楚。我们的实验室已经确定了白三烯B4受体,BLT 1作为炎症和宿主对感染反应的主要调节因子。在自发性肠癌(ApcMin/+)的小鼠模型中,我们观察到BLT 1的缺乏大大增强了肠道肿瘤的发展。这导致了一个中心假设,即BLT 1的缺失通过缺陷的免疫监视和/或改变的微生物肠道稳态来增强结肠肿瘤的发展。促炎介质的丢失增加了炎症和肿瘤的发展,这一明显矛盾的结果表明,不断变化的肠道微环境可能对结直肠癌的发展产生重大影响。本提案将在三个具体目标中检验这一假设。在目的1中,我们将在ApcMin/+小鼠中研究白三烯B4通路介导的肠癌保护机制。目的2在BLT 1 +/+和BLT 1-/-小鼠的背景下建立荷瘤小鼠的免疫功能。目的3将测试新的概念,即缺陷的宿主反应和改变的肠道微生物群是导致BLT 1-/-小鼠结肠肿瘤快速发展的原因。这些研究将提供一个全面的模型系统,以检查炎症和感染对结肠癌发展的相互作用。由于小鼠ApcMin/+模型与人类结肠癌高度相关,因此结果将对人类结肠癌的治疗产生直接和直接的影响。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth.
  • DOI:
    10.1038/ncomms8064
  • 发表时间:
    2015-04-29
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Satpathy SR;Jala VR;Bodduluri SR;Krishnan E;Hegde B;Hoyle GW;Fraig M;Luster AD;Haribabu B
  • 通讯作者:
    Haribabu B
Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARIBABU BODDULURI其他文献

HARIBABU BODDULURI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARIBABU BODDULURI', 18)}}的其他基金

Functional Microbiomics Core-Bodduluri
功能微生物组学核心-Bodduluri
  • 批准号:
    10349568
  • 财政年份:
    2018
  • 资助金额:
    $ 27.87万
  • 项目类别:
Functional Microbiomics Core
功能微生物组学核心
  • 批准号:
    10492098
  • 财政年份:
    2018
  • 资助金额:
    $ 27.87万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8210894
  • 财政年份:
    2009
  • 资助金额:
    $ 27.87万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8015283
  • 财政年份:
    2009
  • 资助金额:
    $ 27.87万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    7635082
  • 财政年份:
    2009
  • 资助金额:
    $ 27.87万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    7032234
  • 财政年份:
    2003
  • 资助金额:
    $ 27.87万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6610703
  • 财政年份:
    2003
  • 资助金额:
    $ 27.87万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6706978
  • 财政年份:
    2003
  • 资助金额:
    $ 27.87万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6858582
  • 财政年份:
    2003
  • 资助金额:
    $ 27.87万
  • 项目类别:
REGULATION OF HIV-1 CORECEPTORS
HIV-1 辅助受体的调节
  • 批准号:
    6019921
  • 财政年份:
    2000
  • 资助金额:
    $ 27.87万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了